Brain cancer breakthrough? epilepsy drug combo trial offers new hope
NCT ID NCT07284069
Summary
This early-stage trial is testing whether two existing drugs—one for epilepsy and one previously studied for blood disorders—can help control aggressive brain cancer when added to standard treatment. Researchers will give 27-36 adults with newly diagnosed glioblastoma these drugs alone and in combination to check safety, find the right doses, and see if they reach the brain tumor effectively. The goal is to find a new treatment approach that could be tested in larger future studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Aarhus University Hospital, Department of Neurosurgery
RECRUITINGAarhus, Denmark, 8200, Denmark
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.